hexadecanesulfonyl fluoride has been researched along with Disease Models, Animal in 2 studies
AM 374: a palmitylsulfonyl fluoride; inhibits anandamide amidase; structure given in first source
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Clinical trials are now required, but are hindered by a paucity of cannabinoids of suitable bioavailability and therapeutic ratio." | 2.41 | Cannabinoids and pain. ( Rice, AS, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lastres-Becker, I | 1 |
| de Miguel, R | 1 |
| De Petrocellis, L | 1 |
| Makriyannis, A | 1 |
| Di Marzo, V | 1 |
| Fernández-Ruiz, J | 1 |
| Rice, AS | 1 |
1 review available for hexadecanesulfonyl fluoride and Disease Models, Animal
| Article | Year |
|---|---|
Cannabinoids and pain.
Topics: Amides; Amidohydrolases; Analgesics; Animals; Arachidonic Acids; Benzoxazines; Brain; Camphanes; Can | 2001 |
1 other study available for hexadecanesulfonyl fluoride and Disease Models, Animal
| Article | Year |
|---|---|
Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amino Acids, Neutral; Animals; Arachidonic Acids; Basal Ganglia; Can | 2003 |